Lockheed Martin Emerges as Leading Bidder for Ultra Maritime in $3.5 Billion Deal
The move would significantly boost its naval sonar, sonobuoy, and torpedo defense portfolio.
Already have an account? Sign in.
The move would significantly boost its naval sonar, sonobuoy, and torpedo defense portfolio.
BMO Capital gives Trevi Therapeutics an Outperform rating and $36 target, citing strong potential for Haduvio as a first-in-class treatment for chronic cough in idiopathic pulmonary fibrosis.
Analyst forecasts show Intel and Samsung struggling to close the gap on A16 and N2 technology.
Genuine Parts lowered its 2026 profit outlook amid weaker consumer demand. CEO Will Stengel denied rumors of a rival acquiring its automotive business.